📰 4 sources covering this story

Pfizer tops estimates, hikes low end of revenue guidance on strength of Eliquis, other drugs

First covered 6 hrs ago · latest take 4 hrs ago. Compare how each outlet is covering it — and rate the sources you trust.

Pfizer tops estimates, hikes low end of revenue guidance on strength of Eliquis, other drugs
CNBC
CNBC4 hrs ago
Pfizer tops estimates, hikes low end of revenue guidance on strength of Eliquis, other drugs
Pfizer said it cut its full-year revenue expectation for its Covid products to $4 billion, down from around $5 billion previously.
Pfizer’s Quarterly Results Beat Expectations on Cancer, Heart Drugs - WSJ
Pfizer’s Quarterly Results Beat Expectations on Cancer, Heart Drugs  WSJ
Reuters
Reuters6 hrs ago
Pfizer beats earnings estimates, targets $2.5 billion in additional cost cuts
Pfizer beats earnings estimates, targets $2.5 billion in additional cost cuts  Reuters
CTV News
CTV News🏁 first to report6 hrs ago
Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis
Pfizer Tuesday slightly raised the lower end of its full-year revenue forecast after beating Wall Street estimates for second-quarter profit, driven by strong demand for blood thinner Eliquis.
Top rated outlets
Outlets are ranked once they have 3+ community ratings — be one of the first to rate.
🏆 Most trusted sources 2026 →
Scores come entirely from reader ratings — rate the sources you read to shape them. How it works →